Search

Displaying results 6971 - 6980 of 8575 in total
  1. Drug

    Adrixetinib

    go.drugbank.com/drugs/DB21620
    Investigational

    Adrixetinib has a monoisotopic molecular weight of 531.17 Da.

  2. Drug

    Friluglanstat

    go.drugbank.com/drugs/DB21652
    Experimental

    Friluglanstat has a monoisotopic molecular weight of 516.12 Da.

  3. Drug

    Canlitinib

    go.drugbank.com/drugs/DB21656
    Experimental

    Canlitinib has a monoisotopic molecular weight of 619.21 Da.

  4. Drug

    Labuxtinib

    go.drugbank.com/drugs/DB21658
    Experimental

    Labuxtinib has a monoisotopic molecular weight of 377.13 Da.

  5. Drug

    D-Tryptophan

    go.drugbank.com/drugs/DB03225
    Experimental

    Tryptophan is one of the 20 standard amino acids, as well as an essential amino acid in the human diet. It is encoded in the standard genetic code as the codon UGG. … It is an essential amino acid as defined by its growth effects on rats.

  6. Drug

    N-Formylmethionine

    go.drugbank.com/drugs/DB04464
    Experimental

    The initiating methionine residue enters the ribosome as N-formylmethionyl tRNA. This process occurs in Escherichia coli and other bacteria as well as in the mitochondria of eucaryotic cells.

  7. Drug

    Amitraz

    go.drugbank.com/drugs/DB11373
    ExperimentalVet approved

    It was generated in 1969 by the Boots Co. in England. Amitraz presents insect repellent effects and hence, it can be used as an insecticide and pesticide.

    Synonyms: N,N'-(methyliminodimethylidyne)bis-2,4-xylidine
  8. Drug

    IMM101

    go.drugbank.com/drugs/DB15851
    Experimental

    It has shown to be safe and well tolerated to complement conventional cancer therapy for patients with melanoma and pancreatic ductal adenocarcinoma [PMID: 21930686; PMID: 30107850; PMID: 27599039]. … As of July 2020, researchers from the Ottawa Hospital and Queen’s University, in partnership with the Canadian Cancer Society-funded Canadian Cancer Trials Group (CCTG), are conducting a trial in over

  9. Drug

    Emibetuzumab

    go.drugbank.com/drugs/DB11849
    Investigational

    Emibetuzumab has been used in trials studying the treatment of Advanced Cancer, Renal Cell Carcinoma, Hepatocellular Cancer, Gastric Adenocarcinoma, and Non-Small Cell Lung Cancer, among others.

  10. Drug

    ENTR-601-44

    go.drugbank.com/drugs/DB17836
    Investigational

    Developed by Entrada Therapeutics, it was investigated for the treatment of Duchenne muscular dystrophy.[L46641]